Counterpoint Mutual Funds LLC Novo Cure LTD Transaction History
Counterpoint Mutual Funds LLC
- $493 Million
- Q3 2024
A detailed history of Counterpoint Mutual Funds LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Counterpoint Mutual Funds LLC holds 29,246 shares of NVCR stock, worth $877,087. This represents 0.09% of its overall portfolio holdings.
Number of Shares
29,246
Previous 11,641
151.23%
Holding current value
$877,087
Previous $199,000
129.65%
% of portfolio
0.09%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding NVCR
# of Institutions
263Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$364 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$355 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$238 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$129 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$90.9 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $3.15B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...